Data is not available at this time.
Fureasu Co., Ltd. operates in Japan's personal services sector, specializing in massage and home healthcare services. The company generates revenue through a diversified portfolio, including home acupuncture, moxibustion massage, and in-home nursing care, catering to both individual and institutional clients. Its franchise model for massage services enhances scalability, while its focus on accessibility—such as support for the visually impaired—differentiates it in a competitive market. Fureasu also provides medical care facility management and home care services, positioning itself as an integrated wellness and healthcare provider. The company’s multi-functional approach, combining traditional therapies with modern care solutions, allows it to serve aging populations and urban professionals seeking convenience. Despite operating in a fragmented industry, Fureasu’s established brand and localized service network strengthen its regional market share.
Fureasu reported revenue of JPY 5.71 billion for FY 2024, with net income of JPY 58.3 million, reflecting modest profitability in a labor-intensive sector. Operating cash flow stood at JPY 172 million, though capital expenditures of JPY -125 million indicate ongoing investments in service infrastructure. The company’s asset-light franchise model likely contributes to manageable operational costs, but margin pressures from wage inflation or regulatory changes remain a risk.
Diluted EPS of JPY 24.55 suggests limited but stable earnings power, supported by recurring service demand. The balance between franchise fees and direct service revenue may enhance capital efficiency, though high debt levels (JPY 3.48 billion) relative to cash (JPY 1.13 billion) could constrain financial flexibility. Further scrutiny of ROIC would clarify capital allocation effectiveness.
The company holds JPY 1.13 billion in cash against total debt of JPY 3.48 billion, indicating leveraged financial positioning. While current liquidity appears adequate, the debt-to-equity ratio warrants monitoring, especially given the capital-intensive nature of healthcare services. Positive operating cash flow provides some buffer for debt servicing.
Growth prospects hinge on Japan’s aging demographics and demand for home healthcare. A dividend of JPY 21.14 per share signals commitment to shareholder returns, though payout sustainability depends on stabilizing profitability. Expansion into underserved regions or digital health integrations could drive future revenue streams.
With a market cap of JPY 1.79 billion and a beta of 0.315, Fureasu is perceived as a low-volatility play in defensive sectors. The valuation likely reflects modest growth expectations and sector-specific risks, such as labor shortages or reimbursement policy changes.
Fureasu’s niche in integrated wellness and franchised services offers resilience against economic cycles. Strategic partnerships or technology adoption could enhance scalability, while regulatory tailwinds in elderly care may support long-term demand. However, execution risks and competitive pressures necessitate cautious optimism.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |